AIM round-up: Ukrproduct, Hurricane Energy, Poolbeg Pharma

Home » UK Shares » AIM Risers and Fallers » AIM round-up: Ukrproduct, Hurricane Energy, Poolbeg Pharma

London’s AIM Index made incremental gains during Tuesday’s session but only managed to recover just a shade over one point by the bell, putting it at 898.24.

Ukrproduct +50%
Hurricane Energy +30%
Poolbeg Pharma +24%
4D Pharma -32%
Verditek -26%

Ukrproduct [LON:UKR] topped the board today, advancing 50% by the bell. However this was off the back of very limited trade and no news from the £1m Ukrainian F&B conglomerate. Obviously subject to how affairs map out in the country, this stock could be set for a strong future, but for now it’s difficult to read anything into the move given the 200% closing spread.

Hurricane Energy [LON:HUR] also fared well, adding 30%. This has helped the stock reverse most of last week’s losses and the rise comes ahead of next week’s AGM which will inevitably be accompanied by some kind of update.

Poolbeg Pharma [LON:POLB] gets the notable mention, up 24%. The stock saw strong gains a month ago following news of those patent applications but it failed to cement the upside and staged a complete reversion. Could today’s gains be the result of fresh bargain hunting and will longer term shareholders look to cash out once more?

4D Pharma [LON:DDDD] was the day’s laggard, off 32% at the close. A pre-AGM presentation was given to investors this morning but seemingly this offered little in the way of inspiration.

Verditek [LON:VDTK] was the second worst performer, off 26% and extending yesterday’s losses. There has been little news from the company for some time and they’re now closing in on the filing deadline for year end results. The wariness of investors seems well founded.

Related
AIM round-up: 4D Pharma, TPXImpact, Tasty (23 Mar 2022)
AIM round-up: Baron Oil, Hurricane Energy, Petroneft Resources (22 Feb 2022)
Hurricane Energy shares down 16% as uncertainty swirls around P6 well (29 Sep 2021)

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.